View Report
November 26, 2025
Batch: GAGLOW11
Measured Result 82.70 mg 118.1% of label claim
Peptide Hubs
Peptide Hubs
Latest Laboratory Result 82.70 mg November 26, 2025 · 118.1% of label claim View
You will save $78.00
Glow Blend 70 mg
Product Information Compound Details
Active Formula BPC 157 / TB 500 / GHK-Cu Blend
70 mg/vialBPC 157 10 mg
TB 500 10 mg
GHK-Cu 50 mg
Total Strength 70 mg/vial
Package 1 Vial
Form Lyophilized Powder
Vial Size 2 mL Vial
Drug Class Research Peptide
Manufacturer Peptide Hubs
$117.00
$195.00
Shipping :
International
U.S. Domestic
Product Overview
Glow Blend 70 mg by Peptide Hubs
Glow Blend 70 mg is a lyophilized multi-peptide research blend manufactured by Peptide Hubs and supplied as a 70 mg/vial powder in a 2 mL vial, containing BPC 157 10 mg, TB 500 10 mg, and GHK-Cu 50 mg.
BPC 157 / TB 500 / GHK-Cu Injectable
Glow Blend 70 mg combines three well-studied research peptides in a single lyophilized vial. BPC 157 is a pentadecapeptide investigated for angiogenic and cytoprotective effects. TB 500 is a fragment of thymosin beta-4 studied for cell migration and tissue repair. GHK-Cu is a copper-binding tripeptide studied for collagen synthesis and skin remodeling. Together, these peptides are referenced in non-medical research contexts for complementary recovery and tissue-remodeling pathways .
Each component of Glow Blend 70 mg operates through a distinct mechanism. BPC 157 has been shown in preclinical models to up-regulate growth hormone receptor expression in tendon fibroblasts and to promote angiogenesis through VEGFR2-Akt-eNOS signaling. TB 500 regulates actin dynamics, promoting cell migration to sites of injury. GHK-Cu delivers copper to cells, where it serves as a cofactor for enzymes involved in collagen cross-linking and extracellular matrix remodeling .
None of the three components in Glow Blend 70 mg are FDA-approved for human use. BPC 157 and GHK-Cu have been evaluated by the FDA for inclusion on the 503A bulk drug substances list, and both remain under regulatory review. TB 500 is on the World Anti-Doping Agency Prohibited List under S2 (Peptide Hormones and Growth Factors). Non-medical use of this blend falls outside approved indications .
Key Benefits of Glow Blend 70 mg
- Three complementary peptides in a single lyophilized vial
- BPC 157 component associated with angiogenic and cytoprotective pathways
- TB 500 component associated with cell migration and actin regulation
- GHK-Cu component associated with collagen synthesis and tissue remodeling
- Manufactured by Peptide Hubs
Formulation
Lyophilized Powder
Glow Blend 70 mg is supplied as a lyophilized (freeze-dried) powder in a 2 mL vial. Reconstitution with an appropriate solvent is required before use in research contexts.
Product Profile
BPC 157 / TB 500 / GHK-Cu Profile
Glow Blend 70 mg is a three-component research peptide blend containing BPC 157 (pentadecapeptide, ~1,419 Da), TB 500 (thymosin beta-4 fragment, ~889 Da), and GHK-Cu (copper tripeptide, ~402.9 Da free base) .
Multi-Peptide Research Blend
Glow Blend 70 mg belongs to the class of multi-component peptide research products, which combine peptides targeting different biological pathways in a single vial. This approach is referenced in non-medical research contexts as a way to study complementary tissue-repair mechanisms simultaneously. The three components of this blend operate through distinct and non-overlapping pathways .
BPC 157 is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. It has been studied for angiogenic and cytoprotective effects in animal models. TB 500 is a synthetic fragment of thymosin beta-4 that binds G-actin, maintaining a pool of actin monomers essential for cell motility and migration. GHK-Cu is a naturally occurring copper-binding tripeptide that declines with age and has been studied for collagen synthesis and anti-inflammatory effects .
In non-medical bodybuilding contexts, this blend is commonly referenced for recovery-focused protocols targeting connective tissue, joint health, and skin quality. None of the components are FDA-approved for human use, and no clinical trials have evaluated this specific combination. Community protocols typically reference 4- to 12-week cycles with 5 days on, 2 days off .
Defining Characteristic
Complementary Triple-Peptide Formulation
Glow Blend 70 mg is distinguished by its three-component design, combining a pentadecapeptide (BPC 157), a thymosin fragment (TB 500), and a copper tripeptide (GHK-Cu) that target different aspects of tissue biology .
Glow Blend 70 mg vs Other Peptide Hubs Preparations
Peptide Hubs offers individual components as separate products for researchers who prefer to control ratios. BPC 157 is available as a standalone 5 mg vial, TB 500 as a standalone 5 mg vial, and GHK-CU as a standalone 50 mg vial.
For a simpler two-peptide recovery blend, TB 500/BPC 157 offers a pre-mixed combination without the GHK-Cu component. For research requiring a reconstitution solution, Bacteriostatic Water is the standard diluent for preparing lyophilized peptides like Glow Blend 70 mg.
Laboratory Testing
Glow Blend 70 mg Lab Reports
Published laboratory reports for Glow Blend 70 mg are shown below with the test date, measured content, and batch number.
View Report
Laboratory results apply to the specific tested sample represented in each published report and should not be interpreted as a measurement of every vial or production batch.
Dosage & Usage
Glow Blend 70 mg Dosage & Usage
The information below is provided for educational reference only. None of the components in Glow Blend 70 mg are FDA-approved human drugs. Their use for any non-medical purpose falls outside approved indications, and no established human dosing regimen exists for this combination .
Typical Dosage Ranges
Because Glow Blend 70 mg lacks FDA approval and published human dose-finding trials, there is no medically established dosage range. In non-medical bodybuilding and research communities, reference ranges are derived from community convention. Commonly referenced ranges are 200–400 mcg per injection administered subcutaneously 5 days on, 2 days off .
| Use Case | Common Reference Range | Injection Frequency |
|---|---|---|
| Recovery-focused protocol (non-medical) | 200–300 mcg | Once daily, 5 days on / 2 off |
| Standard protocol (non-medical) | 300–400 mcg | Once daily, 5 days on / 2 off |
| Cycle length (non-medical) | 4–12 weeks | Followed by 4-week break |
These ranges are community conventions, not evidence-based medical recommendations. No human dose-response relationship has been established for this specific combination of peptides, and individual response is unpredictable .
Reconstitution & Handling
Glow Blend 70 mg is supplied as a lyophilized powder and requires reconstitution before use. A 70 mg vial reconstituted with 2 mL of solvent yields a concentration of 35 mg/mL total peptide, meaning a 300 mcg dose would require drawing approximately 0.01 mL (1 unit on a U-100 insulin syringe).
Reconstituted solution should be stored refrigerated at 2–8°C and protected from light. Avoid repeated freeze-thaw cycles to maintain peptide integrity.
Stacking & Cycle Considerations
Glow Blend 70 mg already combines three peptides, so additional stacking is less common. Some non-medical protocols reference combining this blend with TB 500/BPC 157 for additional recovery support, though this represents a combination of overlapping mechanisms .
Cycle lengths commonly referenced range from 4 to 12 weeks on, followed by a 2- to 4-week break. The 5 days on / 2 days off schedule is common in community protocols .
Important
Individual Response Varies
No human pharmacokinetic or dose-response data exists for Glow Blend 70 mg. All dosage information is derived from community convention and should not be interpreted as medical guidance.
Safety & Information
BPC 157 / TB 500 / GHK-Cu Safety Information
None of the components in Glow Blend 70 mg are FDA-approved for human use. Safety data in humans is extremely limited for all three peptides, and non-medical use carries unknown risks .
Important Safety Information
BPC 157, TB 500, and GHK-Cu have not received FDA approval for human use. BPC 157 and GHK-Cu have been evaluated by the FDA for inclusion on the 503A bulk drug substances list and remain under regulatory review. TB 500 is on the World Anti-Doping Agency Prohibited List under S2 .
Combining three unapproved peptides in a single formulation introduces additional unknown risks. No clinical trials have evaluated the safety or efficacy of this specific combination, and the potential for additive or synergistic adverse effects is unknown.
Important
Non-Medical Use
Glow Blend 70 mg is sold strictly as a research chemical for laboratory use only. It is not intended for human consumption, medical treatment, or veterinary applications. Non-medical use falls outside approved indications .
Potential Adverse Effects
Human safety data for BPC 157, TB 500, and GHK-Cu is minimal. The FDA has noted for BPC 157 potential for immunogenicity, along with minimal establishment of purity, efficacy, or safety. For GHK-Cu, unregulated sourcing introduces risks of contamination and mislabeling, and improper injection technique may cause serious complications .
Community-reported side effects for these peptides include injection site reactions, nausea, dizziness, headache, and fatigue. These reports are anecdotal and not from controlled trials .
Conditions Requiring Medical Evaluation
Given the absence of human safety data for this blend, any consideration of Glow Blend 70 mg use should involve consultation with a qualified healthcare professional. Individuals with active malignancy or a history of cancer should exercise particular caution due to the pro-angiogenic properties of BPC 157 and the theoretical concerns with GHK-Cu .
Monitoring During Use
No established monitoring protocol exists for Glow Blend 70 mg. In research contexts, any adverse reactions should be documented and reported to appropriate authorities.
Product Care
Storage & Handling
Store lyophilized powder at -20°C, sealed, dry, and protected from light. Once reconstituted, store refrigerated at 2–8°C and use within approximately 30 days. Avoid repeated freeze-thaw cycles. Keep out of reach of children.
Further Safety Information
Shipping & Authenticity
Shipping & Product Authenticity
Glow Blend 70 mg is supplied through the official Peptide Hubs distribution chain and shipped in original manufacturer packaging with discreet handling.
USA Domestic 3–5 business days
International 10–15 business days
Order Processing 24–48 business hours
Tracking Provided after dispatch
Direct Supply
Discreet Delivery & Original Packaging
The outer shipping package remains discreet, with privacy-focused handling. Products are supplied through the official Peptide Hubs distribution chain.
What to Expect
- Orders are processed after payment confirmation
- USA Domestic shipping is typically faster when local stock is selected
- International orders include tracking, though update frequency may vary
- Multiple warehouses may result in separate shipments when applicable
Authenticity Verification
To verify your Glow Blend 70 mg product, use the security code on the vial label and cross-check it on the Peptide Hubs official site. Original packaging and manufacturer presentation help reinforce product legitimacy.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Storage
Glow Blend 70 mg Storage
Proper storage conditions help preserve peptide stability and integrity throughout shelf life.
Recommended Conditions
Store lyophilized powder at -20°C, sealed, dry, and protected from light. Under these conditions, the dry powder is stable for extended periods.
Once reconstituted, store refrigerated at 2–8°C and use within approximately 30 days. Avoid repeated freeze-thaw cycles to maintain peptide integrity.
Keep out of reach of children. Follow proper handling practices.
Quick Reference
Do & Don't
- Do store powder at -20°C, sealed and protected from light
- Do keep in original packaging until use
- Do refrigerate reconstituted solution at 2–8°C
- Don't expose to excessive heat or moisture
- Don't subject to repeated freeze-thaw cycles
- Don't use if solution appears cloudy or contains particles
Frequently Asked Questions
Glow Blend 70 mg FAQ
Answers to common questions about Glow Blend 70 mg, multi-peptide research blends, and research compound handling.
What is Glow Blend 70 mg used for?
Glow Blend 70 mg is a research blend of three peptides studied for complementary tissue-repair and remodeling pathways. In non-medical bodybuilding contexts, it is commonly referenced for recovery-focused protocols, though such use falls outside approved indications and lacks clinical validation .
How often should Glow Blend 70 mg be injected?
No established human dosing schedule exists. Community protocols commonly reference once-daily subcutaneous administration at 200–400 mcg, 5 days on and 2 days off, for cycles of 4–12 weeks .
Does Glow Blend 70 mg require PCT?
None of the components in Glow Blend 70 mg suppress endogenous testosterone production, and the blend does not require post-cycle therapy in the way anabolic steroids do. However, any non-medical peptide use should be approached with caution given the absence of human safety data .
What do the components of Glow Blend 70 mg do?
BPC 157 is studied for angiogenic and cytoprotective effects, TB 500 for cell migration and actin regulation, and GHK-Cu for collagen synthesis and tissue remodeling . Each component targets a different aspect of tissue biology.
How long does Glow Blend 70 mg take to work?
No human data establishes a timeline for effects. Community reports suggest recovery-related effects may appear over 2–4 weeks of consistent use, while skin-related effects from the GHK-Cu component may take longer .
Is Glow Blend 70 mg the best recovery peptide blend?
There is no universally “best” recovery peptide blend. Glow Blend 70 mg combines three well-studied peptides, but no clinical trials have evaluated this specific combination. Comparative human data is absent .
What is the difference between Glow Blend 70 mg and TB 500/BPC 157?
Glow Blend 70 mg contains three peptides—BPC 157, TB 500, and GHK-Cu—while TB 500/BPC 157 contains only two. The addition of GHK-Cu in Glow Blend adds a copper-peptide component studied for collagen synthesis .
What is the difference between Glow Blend 70 mg and BPC 157 alone?
Glow Blend 70 mg contains BPC 157 alongside TB 500 and GHK-Cu, while BPC 157 is a single-peptide product. The blend is designed for research into complementary mechanisms, whereas single-peptide products allow isolated study .
Is 400 mcg of Glow Blend 70 mg a lot?
400 mcg is at the upper end of the range commonly referenced in community protocols (200–400 mcg per injection). Without human dose-response data, it is impossible to characterize any amount as appropriate or excessive .
What strength is Glow Blend 70 mg?
Glow Blend 70 mg is labeled at 70 mg total per vial, containing BPC 157 10 mg, TB 500 10 mg, and GHK-Cu 50 mg. It is supplied as a lyophilized powder in a 2 mL vial.
Is Glow Blend 70 mg lab tested?
Yes. A published laboratory report dated November 26, 2025 measured Glow Blend 70 mg at 82.70 mg, equivalent to 118.1% of its 70 mg label claim. The batch number is GAGLOW11.
How should Glow Blend 70 mg be stored?
Store the lyophilized powder at -20°C, sealed, dry, and protected from light. Once reconstituted, refrigerate at 2–8°C and use within approximately 30 days. Avoid repeated freeze-thaw cycles.
Related Offers
Lab Tested
Domestic & International
-40% OFF
Peptide Hubs
Product Information Compound Details
Active Substance Bremelanotide Melanocortin receptor agonist
10 mg/vialStrength 10 mg/vial
Amount 1 Vial Lyophilized powder
Form Lyophilized Powder
Vial Size 2 mL Vial
Drug Class Research Peptide
Manufacturer Peptide Hubs
$24.00
$40.00
Lab Tested
Domestic & International
-40% OFF
Peptide Hubs
Product Information Compound Details
Active Formula KPV / BPC 157 / TB 500 / GHK-Cu Blend
80 mg/vialKPV 10 mg
BPC 157 10 mg
TB 500 10 mg
GHK-Cu 50 mg
Total Strength 80 mg/vial
Package 1 Vial
Form Lyophilized Powder
Vial Size 2 mL Vial
Drug Class Research Peptide
Manufacturer Peptide Hubs
$117.00
$195.00
Domestic & International
-40% OFF
Peptide Hubs
Product Information Compound Details
Active Substance DSIP Delta Sleep-Inducing Peptide (nonapeptide)
10 mg/vialStrength 10 mg/vial
Package 1 Vial
Form Lyophilized Powder
Vial Size 2 mL Vial
Drug Class Research Peptide
Manufacturer Peptide Hubs
$48.00
$80.00